Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

The Real-World Performance of the PF4-Dependent P-Selectin Expression Assay (PEA) As the First-Line Functional Assay for the Diagnosis of Heparin-Induced Thrombocytopenia (HIT)

Joud El Dick, Jackson Hoesley, Rance C. Siniard, Laura J. Taylor, Cari E. Reed, Marisa B. Marques, Jori E. May

Blood (2024) 144 (Supplement 1): 159.

https://doi.org/10.1182/blood-2024-211025

Published: 2024

Journal Articles

Rethinking the Gold Standard: Real-World Performance of the Serotonin Release Assay (SRA) and PF4-Dependent P-Selectin Expression Assay (PEA) in the Diagnosis of Heparin-Induced Thrombocytopenia (HIT)

Jackson Hoesley, Rance C Siniard, Laura J. Taylor, Cari Reed, Marisa B. Marques, Jori E. May

Blood (2022) 140 (Supplement 1): 1215–1216.

https://doi.org/10.1182/blood-2022-165647

Published: 2022

Journal Articles

A Road Paved with Good Intentions: A Platelet Count-Based Alert to Facilitate Diagnosis of Heparin-Induced Thrombocytopenia

Jori E. May, Kimberly D. Martin, Laura J. Taylor, Eric L. Wallace, Marisa B. Marques

Blood (2021) 138 (Supplement 1): 756.

https://doi.org/10.1182/blood-2021-145891

Published: 2021

Journal Articles

Caring for Patients with Sickle Cell Disease during a Pandemic: Continuing to Provide Automated Red Blood Cell Exchange Transfusions in Difficult Times

Richard Curtis Godby, MD, Ashton Kornbrust, Denis Noubouossie, Jose Lima, Marisa B. Marques, MD, Rance C Siniard, MD

Blood (2020) 136 (Supplement 1): 25–26.

https://doi.org/10.1182/blood-2020-142535

Published: 2020

Journal Articles

Quality Improvement Initiatives to Improve Transfusion Safety and Efficiency for Patients Receiving Daratumumab

Richard Curtis Godby, MD, Tammy Gray, BS, Hollie Christopher, BS, MLS, Lance A. Williams, III, MD, Marisa B. Marques, MD

Blood (2019) 134 (Supplement_1): 2100.

https://doi.org/10.1182/blood-2019-126958

Published: 2019

Journal Articles

Exome Sequencing Identifies Glycosylation Defects As a Probable Cause of Immune Thrombotic Thrombocytopenic Purpura

Felipe Massicano, PhD, Elizabeth M. Staley, MD, PhD, Konstantine Halkidis, MD PhD, Nicole K. Kocher, Lance A. Williams, III, MD, Marisa B. Marques, MD, Bryan K. Guillory, MD, Wenjing Cao, MD,PhD, Malay K. Basu, PhD, X. Long Zheng, MD, PhD

Blood (2019) 134 (Supplement_1): 217.

https://doi.org/10.1182/blood-2019-131511

Published: 2019

Journal Articles

Plasma Levels of Histone-DNA Complex and Cell-Free DNA Predict Mortality in Patients with Immune Thrombotic Thrombocytopenic Purpura

Jingrui (Jean) Sui, MD, Konstantine Halkidis, MD PhD, Nicole K. Kocher, Lance A. Williams, III, MD, Radhika Gangaraju, MD, Bryan K. Guillory, MD, Marisa B. Marques, MD, Wenjing Cao, MD,PhD, X. Long Zheng, MD, PhD

Blood (2019) 134 (Supplement_1): 1070.

https://doi.org/10.1182/blood-2019-131585

Published: 2019

Journal Articles

Longitudinal Assessment of Plasma ADAMTS13 Biomarkers Helps Predict Recurrence of Immune Thrombotic Thrombocytopenic Purpura

Jingrui (Jean) Sui, MD, Wenjing Cao, MD,PhD, Mohammad S. Abdelgawwad, MD, Konstantine Halkidis, MD PhD, Nicole K. Kocher, Bryan K. Guillory, MD, Lance A. Williams, III, MD, Marisa B. Marques, MD, Radhika Gangaraju, MD, X. Long Zheng, MD, PhD

Blood (2019) 134 (Supplement_1): 2456.

https://doi.org/10.1182/blood-2019-126093

Published: 2019

Journal Articles

Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in Multiple Myeloma Patients: A Single Institution Experience

FEI FEI, MD, Daniel Peavey, Mariam Youssef, MD, Sondra Dunn, RN, Terry Slover, RN, Nick Boshell, RN, Marisa B. Marques, MD, Luciano J Costa, MD PhD, X. Long Zheng, MD PhD, Lance Williams, MD

Blood (2018) 132 (Supplement 1): 3349.

https://doi.org/10.1182/blood-2018-99-117320

Published: 2018

Journal Articles

Active and Ultra-Large Von Willebrand Factor Is Significantly Elevated in Patients with Immune Thrombotic Thrombocytopenic Purpura

Wenjing Cao, PhD, Alicia Veninga, M.Sc., Elizabeth M. Staley, MD, PhD, Adam Miszta, PhD, Nicole Kocher, B.Sc., Lance Williams, III, MD, Marisa B. Marques, MD, Bas de Laat, MD, PhD, X. Long Zheng, MD PhD

Blood (2018) 132 (Supplement 1): 523.

https://doi.org/10.1182/blood-2018-99-117647

Published: 2018

Journal Articles

Correlation of Direct Antiglobulin Test Strength in Umbilical Cord Blood and Hyperbilirubinemia in ABO Incompatible Neonates with Two Methods

FEI FEI, MD, Marisa B. Marques, MD, Elizabeth M. Staley, MD PhD, Lawrence A. Williams, MD

Blood (2018) 132 (Supplement 1): 5072.

https://doi.org/10.1182/blood-2018-99-110339

Published: 2018

Journal Articles

Differentiating Fat Embolism Syndrome Due to Bone Marrow Necrosis in Patients with Sickle Hemoglobinopathies from Thrombotic Thrombocytopenic Purpura (TTP)

Radhika Gangaraju, MD, Jori May, MD, Paul MacLennan, PhD, Vishnu V.B. Reddy, MD, Marisa B. Marques, MD

Blood (2018) 132 (Supplement 1): 1090.

https://doi.org/10.1182/blood-2018-99-112621

Published: 2018

Journal Articles

Predictors for in-Hospital Mortality in Patients with Autoimmune Thrombotic Thrombocytopenia Purpura (TTP): A Single Center Experience

Huy P. Pham, MD, M.P.H., Wenjing Cao, MD, PhD, Lance A. Williams, MD, Alexander Z. Feldman, MD, Rance C. Siniard, MD, Robin G. Lorenz, MD, PhD, Dheeraj Raju, PhD, Marisa B. Marques, MD, PhD, X. Long Zheng, MD, PhD

Blood (2016) 128 (22): 3853.

https://doi.org/10.1182/blood.V128.22.3853.3853

Published: 2016

Journal Articles

Plasma Levels of Human Neutrophil Peptides and Complement Activation Markers in Patients with Acquired Autoimmune Thrombotic Thrombocytopenic Purpura

Wenjing Cao, MD, PhD, Huy Phu Pham, MD, M.P.H., Lawrence A. Williams, MD, Zheng Ping, MD, PhD, Robin G. Lorenz, MD, PhD, Marisa B. Marques, MD, PhD, X. Long Zheng, MD PhD

Blood (2015) 126 (23): 1147.

https://doi.org/10.1182/blood.V126.23.1147.1147

Published: 2015

Journal Articles

High Percentage of Evanescent Red Cell Antibodies in Patients with Sickle Cell Disease Highlights the Need for a National Antibody Database

Marisa B Marques, MD, Robinna G Lorenz, MDPhD, Lance A Williams, MD

Blood (2015) 126 (23): 3572.

https://doi.org/10.1182/blood.V126.23.3572.3572

Published: 2015

Journal Articles

A new “initial” case of transfusion-related acute lung injury

Mark Steciuk, Marisa B. Marques

Blood (2008) 111 (10): 5257–5258.

https://doi.org/10.1182/blood-2008-03-144709

Published: 2008

Journal Articles

Repeat Borderline or Negative Platelet Factor-4 ELISA May Yield Positive Results in Patients with Clinical Suspicion of Heparin-Induced Thrombocytopenia.

Meredith A. Lakey, MD, David W. Arndt, MT, Marisa B. Marques, MD

Blood (2005) 106 (11): 4014.

https://doi.org/10.1182/blood.V106.11.4014.4014

Published: 2005

NARROW

The Real-World Performance of the PF4-Dependent P-Selectin Expression Assay (PEA) As the First-Line Functional Assay for the Diagnosis of Heparin-Induced Thrombocytopenia (HIT)

Rethinking the Gold Standard: Real-World Performance of the Serotonin Release Assay (SRA) and PF4-Dependent P-Selectin Expression Assay (PEA) in the Diagnosis of Heparin-Induced Thrombocytopenia (HIT)

A Road Paved with Good Intentions: A Platelet Count-Based Alert to Facilitate Diagnosis of Heparin-Induced Thrombocytopenia

Caring for Patients with Sickle Cell Disease during a Pandemic: Continuing to Provide Automated Red Blood Cell Exchange Transfusions in Difficult Times

Quality Improvement Initiatives to Improve Transfusion Safety and Efficiency for Patients Receiving Daratumumab

Exome Sequencing Identifies Glycosylation Defects As a Probable Cause of Immune Thrombotic Thrombocytopenic Purpura

Plasma Levels of Histone-DNA Complex and Cell-Free DNA Predict Mortality in Patients with Immune Thrombotic Thrombocytopenic Purpura

Longitudinal Assessment of Plasma ADAMTS13 Biomarkers Helps Predict Recurrence of Immune Thrombotic Thrombocytopenic Purpura

Evaluation of Pre-Collection Factors and Collection Efficiency Leads to Strong Correlation between Predicted and Actual Peripheral Blood Stem Cell Collection Yields in Multiple Myeloma Patients: A Single Institution Experience

Active and Ultra-Large Von Willebrand Factor Is Significantly Elevated in Patients with Immune Thrombotic Thrombocytopenic Purpura

Correlation of Direct Antiglobulin Test Strength in Umbilical Cord Blood and Hyperbilirubinemia in ABO Incompatible Neonates with Two Methods

Differentiating Fat Embolism Syndrome Due to Bone Marrow Necrosis in Patients with Sickle Hemoglobinopathies from Thrombotic Thrombocytopenic Purpura (TTP)

Predictors for in-Hospital Mortality in Patients with Autoimmune Thrombotic Thrombocytopenia Purpura (TTP): A Single Center Experience

Plasma Levels of Human Neutrophil Peptides and Complement Activation Markers in Patients with Acquired Autoimmune Thrombotic Thrombocytopenic Purpura

High Percentage of Evanescent Red Cell Antibodies in Patients with Sickle Cell Disease Highlights the Need for a National Antibody Database

A new “initial” case of transfusion-related acute lung injury

Repeat Borderline or Negative Platelet Factor-4 ELISA May Yield Positive Results in Patients with Clinical Suspicion of Heparin-Induced Thrombocytopenia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only